REAL-WORLD BIOLOGIC USE AND SWITCHING AMONG ADULTS WITH SEVERE ASTHMA TREATED BY US SUBSPECIALISTS IN THE CHRONICLE STUDY

被引:0
|
作者
Panettieri, Reynold A.
Ledford, Dennis K.
Chipps, Bradley E.
Soong, Weily
Lugogo, Njira L.
Mohan, Arjun
Carstens, Donna D.
Genofre, Eduardo H.
Trudo, Frank
Ambrose, Christopher
机构
关键词
D O I
10.1016/j.chest.2022.08.2241
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:2709A / 2714A
页数:6
相关论文
共 50 条
  • [31] A Real-world Experience With Tezepelumab as the First Biologic Option in Severe Asthma Patients
    Mohan, A.
    Bagheri, A.
    Senn, R.
    Harwood, H.
    Fergan, J.
    Derstine, B.
    Lugogo, N. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [32] Real-World Study of US Adults with Paroxysmal Nocturnal Hemoglobinuria Treated with Pegcetacoplan
    Mulherin, Brian
    Shenoy, Apeksha
    Arnett, Lily
    Jiao, Weiqi
    Guarinoni, Joseph
    Sarda, Sujata
    Min, Jinny
    Dingli, David
    HEMATOLOGY REPORTS, 2024, 16 (04) : 669 - 681
  • [33] Real-world Effectiveness of Dupilumab in Biologic Naive Patients With Asthma: Analysis From the US Advantage Study
    Stanford, R. H.
    Blaiss, M.
    Bleecker, E. R.
    Jacob-Nara, J. A.
    Duh, M.
    Wang, Z.
    Soler, X.
    Hardin, M. E.
    Ye, M.
    Nair, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [34] Real-World Evidence in Prescription Medication Use Among US Adults with Neck Pain
    Huang, Jin-Feng
    Meng, Zhou
    Zheng, Xuan-Qi
    Qin, Zongshi
    Sun, Xiao-Lei
    Zhang, Kai
    Tian, Hai-Jun
    Wang, Xiao-Bing
    Gao, Ze
    Li, Yan Michael
    Wu, Ai-Min
    PAIN AND THERAPY, 2020, 9 (02) : 637 - 655
  • [35] Real-World Outcome Analysis of Continuously and Intermittently Treated Patients with Moderate to Severe Psoriasis after Switching to a Biologic Agent
    Hjalte, Frida
    Carlsson, Katarina Steen
    Schmitt-Egenolf, Marcus
    DERMATOLOGY, 2015, 230 (04) : 347 - 353
  • [36] Biologic Outcomes in US Hispanic and Black Patients With Severe Asthma: Results From the CHRONICLE Study
    Trevor, J.
    Moore, W. C.
    Lugogo, N. L.
    Ledford, D.
    Genofre, E. H.
    Carstens, D.
    Ambrose, C. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [37] Current Biologic Therapies for Severe Asthma and Real-World Data: Are Expectations Being Met?
    Villamanan, Elena
    Laorden, Daniel
    Granda, Paula
    Sobrino, Carmen
    De Andres, Susana
    Carpio, Carlos
    Dominguez-Ortega, Javier
    Romero, David
    Mariscal, Pablo
    de las Vecillas, Leticia
    Quirce, Santiago
    alvarez-Sala, Rodolfo
    AsmaGrave HULP Study Grp, on behalf of AsmaGrave-HULP Study
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (23)
  • [38] Real-world treatment and health care resource use among severe asthma patients in Japan
    To, Yasuo
    Taguchi, Yurie
    Shimazaki, Tatsuya
    Arima, Kazuhiko
    Yu, Eric
    Sven, Demiya
    Iwanaga, Takashi
    RESPIRATORY INVESTIGATION, 2021, 59 (04) : 464 - 477
  • [39] Clinical and economic burden of severe asthma among US patients treated with biologic therapies
    Reibman, Joan
    Tan, Laren
    Ambrose, Chris
    Chung, Yen
    Desai, Pooja
    Llanos, Jean-Pierre
    Moynihan, Meghan
    Tkacz, Joseph
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (03) : 318 - +
  • [40] Real-World Evidence: Infections Among RA Patients Switching from First Biologic DMARD to Another Treatment in the US
    Dore, Robin
    Antonova, Jenya
    Huang, Huan
    Chang, Lawrence
    Wang, Xin
    Genovese, Mark
    ARTHRITIS & RHEUMATOLOGY, 2019, 71